Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hanan Al Rayes & Zahi Touma. (2014) Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus. Drug Design, Development and Therapy 8, pages 2303-2310.
Read now
Read now
Andrew J Leishman, Gary P Sims, Matthew Sleeman & Martin Braddock. (2011) Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity. Expert Opinion on Investigational Drugs 20:1, pages 23-39.
Read now
Read now
Articles from other publishers (18)
James J. Crawford, Jianwen Feng, Hans D. Brightbill, Adam R. Johnson, Matthew Wright, Aleksandr Kolesnikov, Wendy Lee, Georgette M. Castanedo, Steven Do, Nicole Blaquiere, Steven T. Staben, Po-Chang Chiang, Peter W. Fan, Matt Baumgardner, Susan Wong, Robert Godemann, Alice Grabbe, Catharina Wiegel, Swathi Sujatha-Bhaskar, Sarah G. Hymowitz, Nicholas Liau, Peter L. Hsu, Paul A. McEwan, Moulay Hicham Alaoui Ismaili & Matthew L. Landry. (2023) Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design. Bioorganic & Medicinal Chemistry Letters 89, pages 129277.
Crossref
Crossref
Jing Cheng, Xuexin Feng, Zhiqiang Li, Feilong Zhou, Jin-Ming Yang & Yujun Zhao. (2021) Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases. RSC Medicinal Chemistry 12:4, pages 552-565.
Crossref
Crossref
Andrea Fava & Michelle Petri. (2019) Systemic lupus erythematosus: Diagnosis and clinical management. Journal of Autoimmunity 96, pages 1-13.
Crossref
Crossref
Nicole Blaquiere, Georgette M. Castanedo, Jason D. Burch, Leonid M. Berezhkovskiy, Hans Brightbill, Suzanne Brown, Connie Chan, Po-Chang Chiang, James J. Crawford, Teresa Dong, Peter Fan, Jianwen Feng, Nico Ghilardi, Robert Godemann, Emily Gogol, Alice Grabbe, Alison J. Hole, Baihua Hu, Sarah G. Hymowitz, Moulay Hicham Alaoui Ismaili, Hoa Le, Patrick Lee, Wyne Lee, Xingyu Lin, Ning Liu, Paul A. McEwan, Brent McKenzie, Hernani L. Silvestre, Eric Suto, Swathi Sujatha-Bhaskar, Guosheng Wu, Lawren C. Wu, Yamin Zhang, Zoe Zhong & Steven T. Staben. (2018) Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase. Journal of Medicinal Chemistry 61:15, pages 6801-6813.
Crossref
Crossref
Hans D. Brightbill, Eric Suto, Nicole Blaquiere, Nandhini Ramamoorthi, Swathi Sujatha-Bhaskar, Emily B. Gogol, Georgette M. Castanedo, Benjamin T. Jackson, Youngsu C. Kwon, Susan Haller, Justin Lesch, Karin Bents, Christine Everett, Pawan Bir Kohli, Sandra Linge, Laura Christian, Kathy Barrett, Allan Jaochico, Leonid M. Berezhkovskiy, Peter W. Fan, Zora Modrusan, Kelli Veliz, Michael J. Townsend, Jason DeVoss, Adam R. Johnson, Robert Godemann, Wyne P. Lee, Cary D. Austin, Brent S. McKenzie, Jason A. Hackney, James J. Crawford, Steven T. Staben, Moulay H. Alaoui Ismaili, Lawren C. Wu & Nico Ghilardi. (2018) NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus. Nature Communications 9:1.
Crossref
Crossref
Alexis Sentís, Fritz Diekmann, Arturo Llobell, Noemí de Moner, Gerard Espinosa, Jordi Yagüe, Josep Maria Campistol, Eduard Mirapeix & Manel Juan. (2017) Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology. Immunobiology 222:4, pages 620-630.
Crossref
Crossref
Sander W. Tas & Dominique L. P. Baeten. 2016. Suppression and Regulation of Immune Responses. Suppression and Regulation of Immune Responses
143
155
.
Silvia Sánchez-Ramón & Lara Valor. (2014) Tratamiento con gammaglobulinas intravenosas en las enfermedades inflamatorias sistémicas autoinmunitarias: ¿nuevas indicaciones?. Medicina Clínica 143:3, pages 130-133.
Crossref
Crossref
Ignacio Sanz. 2014. Drugs Targeting B-Cells in Autoimmune Diseases. Drugs Targeting B-Cells in Autoimmune Diseases
37
64
.
V Di Caro, B Phillips, C Engman, J Harnaha, M Trucco & N Giannoukakis. (2013)
Retinoic acid-producing,
ex-vivo
-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes
. Clinical and Experimental Immunology 174:2, pages 302-317.
Crossref
Crossref
Zheng Liu & Anne Davidson. (2012) Taming lupus—a new understanding of pathogenesis is leading to clinical advances. Nature Medicine 18:6, pages 871-882.
Crossref
Crossref
Qing-Tong Wang, Yu-Kun Ma, Bei Huang, Dan-Dan Liu & Wei Wei. (2011) Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice. Molecular Immunology 49:1-2, pages 380-386.
Crossref
Crossref
William Stohl, Jean L Scholz & Michael P Cancro. (2011) Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside. Current Opinion in Rheumatology 23:3, pages 305-310.
Crossref
Crossref
Shamael Alsanafi, Carrie Kovarik, Andrew L. Mermelstein & Victoria P. Werth. (2011) Rituximab in the Treatment of Bullous Systemic Lupus Erythematosus. JCR: Journal of Clinical Rheumatology 17:3, pages 142-144.
Crossref
Crossref
Clemens Scheinecker, Michael Bonelli & Josef S. Smolen. (2010) Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. Journal of Autoimmunity 35:3, pages 269-275.
Crossref
Crossref
Michael Bonelli & Clemens Scheinecker. (2010) Systemischer Lupus Erythematodes (SLE). Wiener klinische Wochenschrift Education 5:1, pages 31-47.
Crossref
Crossref
Rei Watanabe, Nobuko Ishiura, Hiroko Nakashima, Yoshihiro Kuwano, Hitoshi Okochi, Kunihiko Tamaki, Shinichi Sato, Thomas F. Tedder & Manabu Fujimoto. (2010) Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity. The Journal of Immunology 184:9, pages 4801-4809.
Crossref
Crossref
Xavier Bosch. (2010) Rituximab in ANCA vasculitis and lupus: bittersweet results. Nature Reviews Nephrology 6:3, pages 137-139.
Crossref
Crossref